← Back to Search

Financial Navigation for Blood Cancer Survivors

N/A

Waitlist Available

Led By Susan K Parsons, MD, MRP

Research Sponsored by Tufts Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial studies how young adult cancer survivors (18-39y) experience financial strain and seeks to find ways to help.

Who is the study for?

This trial is for young adults aged 18-39 in the U.S. who were diagnosed with blood cancer (like leukemia or lymphoma) during childhood or early adulthood, are off treatment or on a stable regimen, and have been living with their diagnosis for at least three years. They must read English and not be dependent on a parent's insurance.

What is being tested?

The study tests financial navigation services to address money-related stress in young adult blood cancer survivors. Participants will receive different levels of support: active guidance, occasional help, or no special assistance from the study to manage financial challenges.

What are the potential side effects?

Since this trial focuses on financial counseling rather than medical intervention, there are no direct physical side effects expected from participating in the study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Personal Financial Wellness Scale (PFW)

Secondary study objectives

Health-Related Quality of Life (HrQoL) Measures

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Active Control

Group I: Active NavigationActive Control1 Intervention

Active navigation with the study-based financial navigator scheduling four check-in meetings throughout the study with the participant. All participants will complete an assessment at baseline, 3 months and 6 months and be invited to participate in an optional interview after the 6-month assessment.

Group II: Ad Hoc NavigationActive Control1 Intervention

Ad hoc navigation in which participant is provided study-based financial navigator to contact as needed. All participants will complete an assessment at baseline, 3 months and 6 months and be invited to participate in an optional interview after the 6-month assessment.

Group III: No study-based NavigationActive Control1 Intervention

No access to a study-based financial navigator, but access to a national hotline through the Leukemia \& Lymphoma Society. All participants will complete an assessment at baseline, 3 months and 6 months and be invited to participate in an optional interview after the 6-month assessment.

Do I qualify?Apply below to find out